|
|
| Line 1: |
Line 1: |
| | | | |
| | ==Solution NMR structure of spider toxin analogue [F5A,M6F,T26L,K28R]GpTx-1== | | ==Solution NMR structure of spider toxin analogue [F5A,M6F,T26L,K28R]GpTx-1== |
| - | <StructureSection load='6mk5' size='340' side='right'caption='[[6mk5]], [[NMR_Ensembles_of_Models | 20 NMR models]]' scene=''> | + | <StructureSection load='6mk5' size='340' side='right'caption='[[6mk5]]' scene=''> |
| | == Structural highlights == | | == Structural highlights == |
| - | <table><tr><td colspan='2'>[[6mk5]] is a 1 chain structure. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6MK5 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6MK5 FirstGlance]. <br> | + | <table><tr><td colspan='2'>[[6mk5]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Grammostola_porteri Grammostola porteri]. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6MK5 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=6MK5 FirstGlance]. <br> |
| - | </td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6mk5 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6mk5 OCA], [http://pdbe.org/6mk5 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6mk5 RCSB], [http://www.ebi.ac.uk/pdbsum/6mk5 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6mk5 ProSAT]</span></td></tr> | + | </td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=6mk5 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6mk5 OCA], [https://pdbe.org/6mk5 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=6mk5 RCSB], [https://www.ebi.ac.uk/pdbsum/6mk5 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=6mk5 ProSAT]</span></td></tr> |
| | </table> | | </table> |
| | == Function == | | == Function == |
| - | [[http://www.uniprot.org/uniprot/TX15_GRAPO TX15_GRAPO]] Potent voltage-gated sodium channel blocker (PubMed:25658507). Potently inhibits the voltage-gated sodium channels Nav1.7/SCN9A (IC(50)=0.58-10 nM) (PubMed:25658507, PubMed:26999206) (By similarity). Shows a moderate activity on Nav1.1/SCN1A (IC(50)=6 nM), Nav1.2/SCN2A (IC(50)=5 nM), Nav1.3/SCN3A (IC(50)=20.3-170 nM), Nav1.4/SCN4A (IC(50)=200-326 nM), and Nav1.6/SCN8A (IC(50)=17 nM) (PubMed:25658507, PubMed:26999206) (By similarity). Shows an unclear inhibition of Nav1.5/SCN5A (IC(50)=140 nM to >10 uM) and Nav1.8/SCN10A (IC(50)=68-12200 nM) (PubMed:25658507, PubMed:26999206) (By similarity). Weakly blocks the low voltage-gated calcium channels Cav3.1/CACNA1G (30% inhibition of the peak current by 9.8 nM of the toxin) (By similarity).[UniProtKB:P0DJA9][UniProtKB:P0DL73]<ref>PMID:25658507</ref> | + | [https://www.uniprot.org/uniprot/TX15_GRAPO TX15_GRAPO] Potent voltage-gated sodium channel blocker (PubMed:25658507). Potently inhibits the voltage-gated sodium channels Nav1.7/SCN9A (IC(50)=0.58-10 nM) (PubMed:25658507, PubMed:26999206) (By similarity). Shows a moderate activity on Nav1.1/SCN1A (IC(50)=6 nM), Nav1.2/SCN2A (IC(50)=5 nM), Nav1.3/SCN3A (IC(50)=20.3-170 nM), Nav1.4/SCN4A (IC(50)=200-326 nM), and Nav1.6/SCN8A (IC(50)=17 nM) (PubMed:25658507, PubMed:26999206) (By similarity). Shows an unclear inhibition of Nav1.5/SCN5A (IC(50)=140 nM to >10 uM) and Nav1.8/SCN10A (IC(50)=68-12200 nM) (PubMed:25658507, PubMed:26999206) (By similarity). Weakly blocks the low voltage-gated calcium channels Cav3.1/CACNA1G (30% inhibition of the peak current by 9.8 nM of the toxin) (By similarity).[UniProtKB:P0DJA9][UniProtKB:P0DL73]<ref>PMID:25658507</ref> |
| | <div style="background-color:#fffaf0;"> | | <div style="background-color:#fffaf0;"> |
| | == Publication Abstract from PubMed == | | == Publication Abstract from PubMed == |
| Line 21: |
Line 21: |
| | __TOC__ | | __TOC__ |
| | </StructureSection> | | </StructureSection> |
| | + | [[Category: Grammostola porteri]] |
| | [[Category: Large Structures]] | | [[Category: Large Structures]] |
| - | [[Category: Schroeder, C I]] | + | [[Category: Schroeder CI]] |
| - | [[Category: Gptx-1 analogue]]
| + | |
| - | [[Category: Peptide-membrane interaction]]
| + | |
| - | [[Category: Spider toxin]]
| + | |
| - | [[Category: Toxin]]
| + | |
| - | [[Category: Voltage-sensitive sodium channel]]
| + | |
| Structural highlights
Function
TX15_GRAPO Potent voltage-gated sodium channel blocker (PubMed:25658507). Potently inhibits the voltage-gated sodium channels Nav1.7/SCN9A (IC(50)=0.58-10 nM) (PubMed:25658507, PubMed:26999206) (By similarity). Shows a moderate activity on Nav1.1/SCN1A (IC(50)=6 nM), Nav1.2/SCN2A (IC(50)=5 nM), Nav1.3/SCN3A (IC(50)=20.3-170 nM), Nav1.4/SCN4A (IC(50)=200-326 nM), and Nav1.6/SCN8A (IC(50)=17 nM) (PubMed:25658507, PubMed:26999206) (By similarity). Shows an unclear inhibition of Nav1.5/SCN5A (IC(50)=140 nM to >10 uM) and Nav1.8/SCN10A (IC(50)=68-12200 nM) (PubMed:25658507, PubMed:26999206) (By similarity). Weakly blocks the low voltage-gated calcium channels Cav3.1/CACNA1G (30% inhibition of the peak current by 9.8 nM of the toxin) (By similarity).[UniProtKB:P0DJA9][UniProtKB:P0DL73][1]
Publication Abstract from PubMed
Gating modifier toxins (GMTs) from spider venom can inhibit voltage gated sodium channels (NaVs) involved in pain signal transmission, including the NaV1.7 subtype. GMTs have a conserved amphipathic structure that allow them to interact with membranes and also with charged residues in regions of NaV that are exposed at the cell surface. ProTx-II and GpTx-1 are GMTs able to inhibit NaV1.7 with high potency, but they differ in their ability to bind to membranes and in their selectivity over other NaV subtypes. To explore these differences and gain detailed information on their membrane-binding ability and how this relates to potency and selectivity, we examined previously described NaV1.7 potent/selective GpTx-1 analogues, and new ProTx-II analogues designed to reduce membrane binding and improve selectivity for NaV1.7. Our studies reveal that the number and type of hydrophobic residues as well as how they are presented at the surface determine the affinity of ProTx-II and GpTx-1 for membranes, and that altering these residues can have dramatic effects on NaV inhibitory activity. We demonstrate that strong peptide-membrane interactions are not essential for inhibiting NaV1.7, and propose that hydrophobic interactions instead play an important role in positioning the GMT at the membrane surface proximal to exposed NaV residues, thereby affecting peptide-channel interactions. Our detailed structure activity relationship study highlights the challenges of designing GMT-based molecules that simultaneously achieve high potency and selectivity for NaV1.7, as single mutations can induce local changes in GMT structure that can have a major impact on NaV-inhibitory activity.
Peptide-membrane interactions affect the inhibitory potency and selectivity of spider toxins ProTx-II and GpTx-1.,Lawrence N, Wu B, Ligutti J, Cheneval O, Agwa AJ, Benfield AH, Biswas K, Craik DJ, Miranda LP, Troeira Henriques S, Schroeder CI ACS Chem Biol. 2018 Dec 3. doi: 10.1021/acschembio.8b00989. PMID:30507158[2]
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
References
- ↑ Murray JK, Ligutti J, Liu D, Zou A, Poppe L, Li H, Andrews KL, Moyer BD, McDonough SI, Favreau P, Stocklin R, Miranda LP. Engineering potent and selective analogues of GpTx-1, a tarantula venom peptide antagonist of the Na(V)1.7 sodium channel. J Med Chem. 2015 Mar 12;58(5):2299-314. doi: 10.1021/jm501765v. Epub 2015 Feb 19. PMID:25658507 doi:http://dx.doi.org/10.1021/jm501765v
- ↑ Lawrence N, Wu B, Ligutti J, Cheneval O, Agwa AJ, Benfield AH, Biswas K, Craik DJ, Miranda LP, Troeira Henriques S, Schroeder CI. Peptide-membrane interactions affect the inhibitory potency and selectivity of spider toxins ProTx-II and GpTx-1. ACS Chem Biol. 2018 Dec 3. doi: 10.1021/acschembio.8b00989. PMID:30507158 doi:http://dx.doi.org/10.1021/acschembio.8b00989
|
